recombin
canarypox
viru
alvac
extens
studi
vaccin
vector
develop
new
vaccin
strategi
chronic
infecti
diseas
cancer
howev
mechan
alvac
initi
immun
respons
complet
elucid
order
determin
type
innat
immun
trigger
alvac
character
gene
express
profil
human
monocyt
deriv
dendrit
cell
mddc
upon
alvac
infect
cell
permiss
poxviru
infect
play
key
role
initi
immun
respons
major
gene
upregul
alvac
belong
type
interferon
signal
pathway
includ
gene
involv
nfb
pathway
upregul
gene
encod
chemokin
direct
target
transcript
factor
among
upregul
dc
secret
follow
exposur
alvac
confirm
elisa
mani
downstream
type
interferon
activ
gene
antivir
activ
pkr
mx
oa
among
other
also
upregul
respons
alvac
among
express
unconjug
form
western
blot
analysi
demonstr
view
result
propos
alvac
induc
type
interferon
antivir
innat
immun
via
cytosol
patternrecognitionreceptor
prr
sens
doublestrand
dna
activ
find
may
aid
design
effect
alvacvector
vaccin
viral
vector
increasingli
use
vaccin
deliveri
system
advantag
use
viral
vector
includ
abil
carri
gene
encod
multipl
antigen
abil
infect
cell
therebi
stimul
humor
cellular
arm
immun
system
poxvirus
compris
larg
famili
dsdna
virus
replic
cytoplasm
capabl
infect
broad
rang
anim
speci
recombin
canarypox
viru
alvac
replic
limit
avian
host
alvacvector
vaccin
encod
viral
tumor
antigen
administ
human
shown
safe
immunogen
alvac
accommod
larg
number
exogen
gene
larg
dsdna
genom
specif
humor
cellular
immun
respons
rais
product
besid
antigen
deliveri
function
alvac
also
possess
potent
adjuv
activ
howev
mechan
involv
immunopotenti
alvac
well
understood
previous
shown
alvac
enhanc
humor
cellular
immun
respons
coinject
protein
antigen
mous
model
precis
alvac
increas
level
antigenspecif
igg
antibodi
number
secret
cell
respons
coinject
cytomegaloviru
cmv
gb
human
immunodefici
viru
hiv
tat
protein
antigen
compar
antigen
alon
adjuv
effect
alvac
depend
presenc
produc
natur
killer
nk
cell
neutrophil
infiltr
alvac
inject
site
demonstr
boudet
et
al
also
suggest
alvac
induc
proinflammatori
mechan
although
full
replic
canarypox
viru
restrict
avian
speci
mammalian
cell
infect
viral
well
exogen
protein
express
detect
earli
one
hour
postinfect
murin
human
cell
myeloid
lineag
particularli
immatur
mddc
readili
infect
alvac
result
matur
cell
present
studi
also
observ
dc
partial
matur
follow
alvac
infect
immatur
mddc
given
key
role
play
dc
orient
initi
acquir
immun
respons
particularli
prime
cell
abil
alvac
potenti
deliv
foreign
antigen
directli
potent
antigenpresentingcel
apc
increas
attract
vaccin
vector
although
immunogen
indic
cmv
limit
immunogen
alvac
report
model
hiv
defin
number
cytotox
cell
encod
antigen
deliv
intramuscularli
alvac
induc
inconsist
antigenspecif
cytotox
tcell
respons
hiv
one
third
volunt
better
understand
molecular
mechan
action
alvac
would
provid
insight
enhanc
efficaci
futur
vaccin
develop
current
studi
aim
identifi
pattern
gene
express
human
immatur
dendrit
cell
dc
upon
alvac
infect
microarray
technolog
compar
gene
signatur
alvac
treat
nontreat
mddc
reveal
number
pertin
upregul
gene
belong
famili
gene
cytokin
transcript
regul
rna
helicas
ubiquitin
isgyl
antivir
nucleaseand
antigenprocess
gene
major
gene
upregul
follow
alvac
infect
involv
type
ifn
pathway
contrast
gene
involv
nfb
signal
pathway
lead
product
proinflammatori
cytokin
upregul
gene
encod
chemokin
direct
target
transcript
factor
upregul
respons
alvac
protein
secret
supernat
alvac
infect
dc
confirm
elisa
express
number
known
interferon
respons
gene
well
antivir
gene
like
oa
mx
pkr
enhanc
human
mddc
cell
follow
alvac
infect
studi
focus
gene
view
increas
evid
suggest
role
regul
immun
respons
induct
free
form
human
mddc
confirm
western
blot
analysi
result
support
hypothesi
alvac
activ
mediat
induct
type
ifn
signal
cascad
cytosol
patternrecognit
receptor
prr
sens
dsdna
virus
recent
report
dnadepend
activ
ifnregulatori
molecul
dai
lyophil
recombin
canarypox
vector
alvachiv
sanofipasteur
marci
letoil
franc
contain
gene
envelop
strain
link
transmembran
portion
strain
lai
gene
lai
gag
encod
entir
gag
protein
use
alvac
reconstitut
steril
salin
medium
prior
usag
vaccin
use
studi
gmp
clinic
grade
verifi
free
lipopolysaccharid
lp
impur
heparin
human
blood
obtain
healthi
donor
french
blood
bank
ef
rhonealp
peripher
blood
mononuclear
cell
pbmc
isol
centrifug
lymphoprep
gradient
axisshield
oslo
norway
monocyt
purifi
total
pbmc
posit
select
use
magnet
bead
miltenyi
biotec
bergischgladbach
germani
obtain
immatur
dc
monocyt
cultur
rpmi
supplement
fc
presenc
ngml
gmcsf
ngml
day
day
puriti
cultur
analyz
flow
cytometri
percentag
posit
cell
use
experi
exceed
immatur
dc
prepar
describ
cultur
cellsml
rpmi
supplement
fc
presenc
alvac
multipl
infect
moi
gml
poli
c
invivogen
san
diego
ca
incub
c
either
h
alvac
left
togeth
dc
indic
time
wash
indic
u
human
leukocyt
interferon
huifn
pbl
biomed
laboratori
gml
neutral
interferon
alphabeta
receptor
chain
human
antibodi
fitzgerald
concord
gml
nonneutr
interferon
alphabeta
receptor
chain
antibodi
fitzgerald
ad
cultur
incub
time
immatur
dc
infect
alvac
describ
els
incub
presenc
ngml
lp
invivogen
toulous
franc
posit
control
left
untreat
neg
control
h
indic
time
dc
wash
resuspend
pb
fc
nan
label
mab
specif
dako
glostrup
denmarkl
hladr
purchas
bd
bioscienc
franklin
lake
nj
cell
acquir
analyz
flow
cytometri
use
facscalibur
bd
bioscienc
result
analyz
use
cellquest
pro
tm
softwar
bd
bioscienc
total
rna
isol
immatur
dc
prepar
describ
use
nucleospin
rna
ii
kit
macherey
nagel
dueren
germani
accord
manufactur
protocol
briefli
mddc
ml
rpmi
supplement
fc
lglutamin
penicillinstreptomycin
stimul
moi
alvac
h
h
cell
pellet
wash
twice
pb
cell
lyse
l
lysi
buffer
nucleospin
ii
kit
macheri
nagel
supplement
l
rna
elut
column
use
l
rnasefre
h
prewarm
c
concentr
qualiti
rna
measur
use
spectrophotomet
nanodrop
technolog
wilmington
de
agil
bioanalyz
agil
technolog
palo
alto
ca
respect
low
rna
input
fluoresc
linear
amplif
kit
agil
technolog
use
gener
cyanin
cyanin
complimentari
rna
crna
first
total
rna
transcrib
cdna
use
oligo
dtpromot
primer
mmlvrevers
transcriptas
next
crna
synthes
doublestrand
cdna
use
rna
polymeras
simultan
incorpor
cyanin
cyanin
ctp
perkin
elmer
waltham
label
complet
label
crna
purifi
rnaeasi
mini
kit
qiagen
valencia
ca
follow
manufactur
protocol
use
spectrophotomet
nanodrop
technolog
concentr
amount
dye
incorpor
amplifi
crna
measur
purif
label
rna
g
differ
label
sampl
combin
fragment
subsequ
hybrid
whole
human
genom
oligomicroarray
slide
k
agil
technolog
hybrid
wash
slide
perform
describ
manufactur
protocol
agil
technolog
slide
scan
use
scanner
genepix
person
axon
instrument
union
citi
ca
fluoresc
intens
featur
array
obtain
use
genepix
pro
softwar
rosetta
resolv
rosetta
biosoftwar
seattl
wa
ingenu
pathway
analysi
ingenu
system
redwood
citi
ca
softwar
use
analysi
two
dyeswap
hybrid
perform
donor
one
untreat
sampl
label
alvacinfect
sampl
label
second
label
revers
doubl
label
use
abolish
dyespecif
label
hybrid
differ
rna
extract
human
mddc
infect
alvac
moi
h
stimul
poli
c
gml
describ
revers
transcript
rt
pcr
analysi
carri
use
superscript
ii
revers
transcriptas
kit
invitrogen
briefli
first
strand
synthesi
cdna
reaction
mixtur
incub
c
h
follow
genespecif
primer
use
amplif
monocyt
deriv
dendrit
cell
mddc
gener
describ
day
cultur
resuspend
rpmi
supplement
fc
concentr
cellsml
cell
infect
moi
alvac
uml
human
leukocyt
interferon
hifn
pbl
biomed
laboratori
new
brunswick
nj
h
c
incub
cell
lyse
addit
lysi
buffer
mm
trishcl
mm
nacl
sodium
deoxychol
proteas
inhibitor
sourc
cell
debri
remov
centrifug
rpm
min
sd
page
sampl
buffer
biorad
laboratori
hercul
ca
ad
protein
extract
boil
min
follow
separ
whole
cell
extract
mddc
per
lane
reduc
sdspage
electrophoresi
sampl
transfer
hybondpvdf
ge
healthcar
uk
block
tb
contain
sigmaaldrich
st
loui
mo
skim
milk
bd
franklin
lake
nj
room
temperatur
rt
one
hour
membran
wash
incub
overnight
polyclon
antibodi
cell
signal
technolog
danver
c
h
rt
membran
wash
three
time
incub
secondari
antirabbithrp
antibodi
ge
healthcar
uk
h
rt
blot
develop
use
ecl
plu
ge
healthcar
uk
order
verifi
equal
protein
load
membran
wash
block
describ
incub
h
antigapdh
abcam
cambridg
uk
directli
coupl
hrp
cell
supernat
collect
h
vitro
stimul
frozen
c
analysi
cytokin
supernat
quantifi
sandwich
elisa
follow
manufactur
protocol
use
commerci
avail
human
duoset
kit
r
system
minneapoli
mn
human
elisa
kit
pbl
biomed
laboratori
human
elisa
kit
fujirebio
inc
tokyo
japan
human
immatur
mddc
obtain
cultur
posit
monocyt
pbmc
healthi
volunt
presenc
gmcsf
day
flow
cytometr
analysi
perform
assess
puriti
phenotyp
posit
neg
fig
confirm
alvac
induc
dc
matur
previous
describ
human
cell
mous
bone
marrow
deriv
dendrit
cell
immatur
mddc
cultur
h
presenc
alvac
moi
prior
dose
respons
experi
use
murin
human
data
shown
dc
indic
moi
optim
dose
dc
stimul
minim
cell
death
dc
treat
lp
ngml
left
untreat
use
posit
neg
control
respect
expect
alvac
induc
upregul
maturationassoci
surfac
marker
hladr
although
lesser
extent
posit
control
lp
fig
surprisingli
contrast
lp
stimul
alvac
fail
induc
express
molecul
recent
shown
import
dc
mediat
cell
activ
product
kinet
studi
conduct
order
determin
optim
time
point
alvac
infect
gene
express
analysi
immatur
mddc
singl
donor
infect
alvac
moi
h
gene
express
evalu
microarray
analysi
data
shown
sinc
number
differenti
regul
gene
highest
h
postinfect
time
point
chosen
experi
mddc
addit
minim
viral
cytopath
effect
expect
occur
earli
time
point
report
guerra
et
al
mva
nyvac
poxviru
vector
rna
isol
alvactr
untreat
mddc
four
differ
healthi
volunt
upon
h
infect
transcrib
label
complimentari
rna
describ
section
differenti
label
sampl
distinguish
crna
treat
untreat
cell
combin
hybrid
oligom
microarray
slide
repres
uniqu
human
gene
transcript
minimum
chang
express
pvalu
less
criteria
use
select
differenti
regul
gene
condit
total
differenti
upregul
differenti
downregul
gene
identifi
extens
variat
number
upand
downregul
gene
observ
among
four
donor
therefor
focus
analysi
gene
differ
regul
four
donor
refer
coreregul
gene
shown
fig
coreupregul
gene
iden
tifi
fig
contrast
coredownregul
gene
found
fig
therefor
investig
downregul
gene
present
studi
use
ingenu
pathway
analyz
coreupregul
gene
recogn
known
gene
classifi
accord
molecular
function
select
shown
tabl
sixtyf
incorpor
network
basi
molecular
interact
inform
found
within
ingenu
pathway
knowledg
base
decreas
order
magnitud
biolog
function
belong
immun
respons
viral
function
cell
death
cellular
growth
prolifer
cellular
motil
gene
express
fig
major
gene
identifi
associ
one
biolog
function
gene
involv
immun
respons
shown
tabl
list
immunerel
gene
includ
chemokin
eg
antivir
protein
eg
interferon
respons
gene
etc
adaptor
tlr
signal
antigen
process
interferon
signal
among
mani
other
see
complet
list
supplementari
data
induc
interferon
regulatori
factor
significantli
increas
mean
fold
chang
tabl
human
mddc
four
donor
upon
alvac
infect
induc
interferon
regulatori
factor
togeth
latter
constitut
express
major
cell
type
key
regul
type
interferon
ifn
gene
express
respons
pathogen
associ
molecular
pattern
pamp
via
either
transmembran
toll
like
receptor
tlr
cytosol
patternrecognit
system
activ
latter
constitut
present
small
amount
occur
phosphoryl
format
homoand
heterodim
dimer
transloc
nucleu
promot
gene
transcript
fig
follow
activ
receptor
secret
ifn
express
molecul
well
type
ifn
induc
positivefeedback
loop
amplifi
signal
pathway
surprisingli
upregul
gene
express
observ
two
four
donor
express
upregul
mddc
donor
includ
microarray
analysi
test
reversetranscripas
pcr
rtpcr
express
highest
level
h
alvac
infect
accord
positivefeedback
loop
fig
neither
detect
supernat
alvac
infect
mddc
elisa
detect
level
pgml
explain
observ
consid
subtyp
express
celltyp
donor
stimuli
depend
subtyp
human
repres
microarray
chip
subtyp
present
microarray
chip
furthermor
mddc
known
poor
produc
type
ifn
mainli
secret
plasmacytoid
dc
precursor
therefor
level
type
ifn
supernat
might
detect
limit
assay
use
observ
signal
molecul
downstream
ifn
receptor
latter
three
donor
upregul
alvac
infect
mddc
consist
hypothesi
alvac
trigger
type
ifn
signal
pathway
furthermor
ifn
respons
gene
posit
regul
antivir
protein
oa
mx
pkr
indic
red
squar
fig
among
gene
upregul
respons
alvac
among
immun
responserel
gene
upregul
mddc
respons
alvac
infect
sever
encod
chemokin
determin
strong
upregul
transcript
alvac
tabl
correl
express
protein
level
secret
cultur
supernat
alvac
stimul
mddc
evalu
human
mddc
incub
h
alvac
moi
subsequ
supernat
collect
concentr
measur
elisa
accord
enhanc
gene
transcript
mddc
releas
high
amount
respons
alvac
fig
result
confirm
previou
find
mous
model
high
level
secret
bone
marrow
deriv
dendrit
cell
respons
alvac
observ
addit
find
support
hypothesi
alvac
activ
signal
pathway
activ
form
directli
target
gene
transcript
next
role
type
ifn
respons
elicit
mddc
upon
alvac
infect
releas
investig
shown
fig
mddc
infect
alvac
presenc
antiifn
type
receptor
neutral
antibodi
secret
significantli
lower
level
either
mddc
infect
alvac
alon
alvac
presenc
nonneutr
antiifn
type
receptor
antibodi
interferon
alpha
induc
releas
mddc
lesser
extent
alvac
secret
complet
block
neutral
antiifn
type
receptor
antibodi
find
strongli
argu
favor
releas
type
ifn
system
could
detect
elisa
experi
therefor
result
support
key
role
type
ifn
amplif
secret
mddc
respons
alvac
infect
accord
propos
mechan
action
fig
belong
ubiquitinlik
protein
modifi
famili
togeth
deconjug
conjug
enzym
found
consist
highli
upregul
averag
alvac
treat
mddc
tabl
interferon
via
mediat
pathway
strongli
activ
product
free
well
protein
isgyl
conjugationdeconjug
target
protein
via
specif
enzym
whose
express
also
regul
type
ifn
although
function
consequ
isgyl
yet
complet
understood
increas
evid
suggest
role
innat
antivir
respons
free
form
describ
interferoninduc
cytokin
immunoregulatori
properti
consid
potenti
role
ifn
mediat
innat
antivir
respons
analyz
effect
alvac
interferon
respons
gene
mddc
evalu
induct
mddc
follow
alvac
infect
protein
level
western
blot
analysi
human
mddc
cultur
presenc
moi
alvac
human
leukocyt
interferon
ifn
posit
control
h
cell
harvest
lyse
subject
sdspage
subsequ
analyz
western
blot
band
kda
correspond
expect
size
free
form
detect
alvac
well
ifn
treat
mddc
untreat
mddc
equal
protein
load
verifi
blot
membran
housekeep
gene
gapdh
fig
data
confirm
induct
respons
alvac
protein
level
analys
establish
also
releas
supernat
therebi
influenc
cell
type
order
optim
benefit
prophylact
therapeut
immun
strategi
particularli
target
cancer
viral
infect
vaccin
need
abl
induc
sustain
cellular
immun
respons
alvac
recombin
canarypox
viru
consid
good
candid
vaccin
vector
potenti
meet
need
alvac
vaccin
construct
induc
specif
cellular
humor
immun
respons
multipl
pathogen
good
safeti
profil
moreov
sever
canarypox
viru
recombin
vaccin
licens
veterinari
use
alvac
engin
encod
differ
foreign
antigen
contrast
vaccinia
viru
vector
problem
preexist
immun
vector
circumv
addit
antigen
carrier
function
also
report
alvac
exert
adjuv
effect
administ
recombin
protein
antigen
mice
properti
like
link
stimul
innat
immun
system
alvac
viru
infect
innat
immun
initi
cell
sens
foreign
molecul
known
pathogen
associ
molecular
pattern
pamp
patternrecognit
receptor
prr
two
class
prr
identifi
transmembran
prr
includ
tlr
scaveng
lectinlik
receptor
cytosol
prr
includ
nod
among
other
tolllik
receptor
sens
bacteri
viral
pamp
lead
secret
supernat
collect
level
quantifi
elisa
result
express
mean
concentr
standard
error
repres
three
independ
experi
infect
mddc
viral
vector
alvac
induc
secret
partial
inhibit
antityp
ifn
receptor
antibodi
expect
nonneutr
antityp
ifn
receptor
antibodi
use
neg
control
effect
releas
proinflammatori
cytokin
via
nfkb
signal
pathway
tlr
secret
type
ifn
via
signal
transduc
cytoplasm
nodlik
receptor
detect
intracellular
bacteri
pamp
detect
virusderiv
rna
lead
activ
nfb
signal
cascad
exist
cytoplasm
dsdna
sensor
long
suspect
sinc
dna
virus
replic
cytoplasm
abl
induc
type
interferon
respons
recent
toneguchi
cowork
discov
first
cytosol
dsdna
sensor
dai
ligat
lead
type
ifn
gene
induct
independ
tlr
activ
evid
alvac
trigger
innat
immun
respons
specif
pathway
downstream
alvac
infect
yet
elucid
sever
recent
paper
demonstr
attenu
strain
vaccinia
viru
mva
nyvac
trigger
tlrdepend
tlrindepend
signal
pathway
elicit
proinflammatori
cytokin
type
ifn
studi
analyz
gene
profil
human
mddc
follow
alvac
infect
determin
innat
pathway
preferenti
induc
viru
vector
dendrit
cell
select
sinc
permiss
alvac
infect
crucial
orchestr
immun
respons
major
gene
upregul
alvac
belong
type
ifn
pathway
interact
ifn
receptor
promot
activ
signal
transduc
heterotrim
compos
transloc
nucleu
complex
activ
transcript
gene
contribut
posit
feedback
regul
ifn
pathway
found
transcript
upregul
respons
alvac
addit
express
interferon
induc
antivir
gene
oa
pkr
mx
enhanc
follow
alvac
infect
mddc
howev
gene
involv
nfb
signal
cascad
found
upregul
human
mddc
upon
alvac
infect
light
result
propos
alvac
dsdna
viru
resid
cytoplasm
cell
induc
interferonmedi
innat
immun
respons
depend
tlrindepend
way
recognit
cytosol
dsdna
sens
prr
recent
report
dai
molecul
upregul
transcript
protein
express
two
molecul
directli
regul
outlin
fig
follow
alvac
infect
human
mddc
consist
hypothesi
furthermor
fact
alvac
infect
mddc
secret
reduc
level
presenc
neutral
type
ifnreceptor
antibodi
suggest
primari
effect
alvac
secondari
effect
type
ifn
mddc
therebi
support
propos
model
chemotact
factor
cell
nk
cell
express
receptor
recent
studi
neutral
antibodi
defici
mice
demonstr
absenc
function
result
increas
mortal
reduc
cell
infiltr
brain
mice
intracerebr
infect
murin
coronaviru
illustr
import
chemokin
cocoordin
protect
immun
respons
viral
pathogen
addit
releas
might
attract
nk
cell
dc
rich
area
bring
close
contact
therebi
trigger
downstream
h
respons
secret
demonstr
human
mddc
secret
high
level
follow
incub
alvac
thu
confirm
microarray
result
well
data
obtain
vivo
mice
follow
alvac
inject
ubiquitinlik
protein
modifi
whose
gene
express
induc
sever
stimuli
besid
type
interferon
one
earliest
isg
induc
lp
retino
acid
campothecin
radiat
conjug
intracellular
protein
target
revers
process
control
conjug
enzym
deconjug
enzym
respect
enzym
induc
type
interferon
current
isgyl
protein
identifi
among
antivir
protein
pkr
mxa
effect
isgyl
protein
function
distribut
stabil
yet
fulli
understood
howev
accumul
evid
includ
abil
mani
virus
either
inhibit
product
free
format
conjug
indic
antivir
role
protein
free
form
describ
interferoninduc
cytokin
immunoregulatori
properti
human
lymphocyt
monocyt
releas
cultur
medium
follow
vitro
stimul
free
detect
serum
patient
furthermor
shown
recombin
stimul
product
lymphocyt
increas
prolifer
nk
cell
show
first
time
alvac
infect
human
mddc
induc
gene
express
conjug
deconjug
enzym
furthermor
demonstr
protein
express
enhanc
alvac
infect
mdcc
western
blot
analysi
fig
microarray
data
fail
show
upregul
detect
enhanc
express
two
four
donor
recent
data
suggest
express
differ
subtyp
human
celltyp
stimulu
specif
fact
subtyp
repres
microarray
chip
may
explain
lack
gene
upregul
observ
microarray
data
howev
secret
typei
ifn
alvac
infect
dc
indirectli
demonstr
reduc
capac
cell
secret
presenc
type
ifnreceptor
neutral
antibodi
fig
surprisingli
gene
transcript
also
upregul
alvac
four
donor
adaptor
molecul
essenti
tlr
signal
lead
product
proinflammatori
cytokin
except
also
requir
tlr
signal
result
type
interferon
secret
sinc
found
evid
enhanc
proinflammatori
cytokin
gene
transcript
follow
alvac
infect
upon
analysi
microarray
result
type
interferon
secret
via
involv
activ
induct
might
attribut
function
rather
adaptor
one
studi
confirm
alvac
infect
induc
matur
mddc
howev
made
addit
observ
oppos
lp
stimul
alvac
induc
lower
level
costimulatori
molecul
fail
upregul
demonstr
essenti
dc
mediat
cell
activ
secret
result
suggest
alvac
induc
full
dc
matur
consequ
find
activ
specif
cell
respons
alvac
encod
antigen
investig
present
studi
great
interest
subject
research
overal
result
highlight
abil
recombin
canarypox
viral
vector
alvac
induc
type
interferonmedi
innat
antivir
immun
respons
human
mddc
possibl
cytosol
patternrecognit
system
respect
stimul
innat
immun
respons
essenti
develop
effect
acquir
immun
respons
foreign
encod
antigen
find
offer
new
insight
design
effect
alvacvector
vaccin
